Drugs / HBV DNA Vaccine
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01487876 | Sep 2011 → Aug 2012 | chronic hepatitis B virus infection | Fuqiang Yang | Unknown | No outcome recorded |
| Phase 2 | NCT01189656 | Jan 2009 → Nov 2010 | chronic hepatitis B virus infection | The 458 Hospital of Chinese PLA | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HBV DNA vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01487876 ↗ |
| Known as | Therapeutic Double-plasmid HBV DNA Vaccine | “Therapeutic Double-plasmid HBV DNA Vaccine” NCT01189656 ↗ |
| Modality | Vaccine | “Therapeutic Double-plasmid HBV DNA Vaccine” NCT01189656 ↗ |